Percutaneous absorption and chemical carcinogenesis.
D000181:Acrylonitrile / Q000009:adverse effects; D001151:Arsenic / Q000009:adverse effects; D001608:Beryllium / Q000009:adverse effects; D002273:Carcinogens / Q000494:pharmacology; D002737:Chloroprene / Q000009:adverse effects; D002857:Chromium / Q000009:adverse effects; D006202:Hair Dyes / Q000009:adverse effects; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects; D009369:Neoplasms / Q000139:chemically induced*; D009532:Nickel / Q000009:adverse effects; D009602:Nitrosamines / Q000009:adverse effects; D010969:Plastics / Q000009:adverse effects; D012869:Skin Absorption / Q000187:drug effects*; D013343:Styrenes / Q000009:adverse effects
D002273:Carcinogens; D006202:Hair Dyes; D006834:Hydrazines; D009602:Nitrosamines; D010969:Plastics; D013343:Styrenes; D002857:Chromium; D002737:Chloroprene; D009532:Nickel; D000181:Acrylonitrile; D001151:Arsenic; D001608:Beryllium